TTM
$1.45B
YoY change
+1225.6%
5Y CAGR
—
Peak year (2025)
$1.34B
Cumulative operating income
$2.50B
Operating Income history chart for Incyte (INCY) from 1993 to 2025
Latest: $1.34B
Operating Income growth chart for Incyte (INCY) from 1993 to 2025
Latest: +1225.6%
Operating Income history table for Incyte (INCY) from 1993 to 2025
| 2025 | $1.34B | +1225.6% | +$1.24B | ||
| 2024 | $101.29M | -84.5% | −$554.06M | ||
| 2023 | $655.36M | +10.8% | +$63.73M | ||
| 2022 | $591.63M | +1.0% | +$5.85M | ||
| 2021 | $585.78M | -322.2% | +$849.45M | ||
| 2020 | −$263.68M | -165.6% | −$665.68M | ||
| 2019 | $402.01M | +211.1% | +$272.78M | ||
| 2018 | $129.22M | -153.1% | +$372.61M | ||
| 2017 | −$243.39M | -267.9% | −$388.38M | ||
| 2016 | $145.00M | +186.3% | +$94.35M | ||
| 2015 | $50.65M | -1154.4% | +$55.45M | ||
| 2014 | −$4.80M | -70.2% | +$11.30M | ||
| 2013 | −$16.10M | -1502.6% | −$17.25M | ||
| 2012 | $1.15M | -100.8% | +$144.33M | ||
| 2011 | −$143.18M | -1119.2% | −$157.23M | ||
| 2010 | $14.05M | -110.1% | +$153.82M | ||
| 2009 | −$139.77M | -12.3% | +$19.52M | ||
| 2008 | −$159.29M | +86.8% | −$74.01M | ||
| 2007 | −$85.28M | +10.9% | −$8.42M | ||
| 2006 | −$76.86M | -23.7% | +$23.92M | ||
| 2005 | −$100.78M | -32.3% | +$48.07M | ||
| 2004 | −$148.85M | -0.3% | +$499.00K | ||
| 2003 | −$149.35M | +12.6% | −$16.73M | ||
| 2002 | −$132.63M | +105.0% | −$67.93M | ||
| 2001 | −$64.70M | +3.4% | −$2.11M | ||
| 2000 | −$62.59M | +131.8% | −$35.59M | ||
| 1999 | −$27.00M | -321.3% | −$39.20M | ||
| 1998 | $12.20M | +238.9% | +$8.60M | ||
| 1997 | $3.60M | -140.4% | +$12.50M | ||
| 1996 | −$8.90M | -18.3% | +$2.00M | ||
| 1995 | −$10.90M | -9.9% | +$1.20M | ||
| 1994 | −$12.10M | +146.9% | −$7.20M | ||
| 1993 | −$4.90M | — | — |
- 2025$1.34B+1225.6%
- 2024$101.29M-84.5%
- 2023$655.36M+10.8%
- 2022$591.63M+1.0%
- 2021$585.78M-322.2%
- 2020−$263.68M-165.6%
- 2019$402.01M+211.1%
- 2018$129.22M-153.1%
- 2017−$243.39M-267.9%
- 2016$145.00M+186.3%
- 2015$50.65M-1154.4%
- 2014−$4.80M-70.2%
- 2013−$16.10M-1502.6%
- 2012$1.15M-100.8%
- 2011−$143.18M-1119.2%
- 2010$14.05M-110.1%
- 2009−$139.77M-12.3%
- 2008−$159.29M+86.8%
- 2007−$85.28M+10.9%
- 2006−$76.86M-23.7%
- 2005−$100.78M-32.3%
- 2004−$148.85M-0.3%
- 2003−$149.35M+12.6%
- 2002−$132.63M+105.0%
- 2001−$64.70M+3.4%
- 2000−$62.59M+131.8%
- 1999−$27.00M-321.3%
- 1998$12.20M+238.9%
- 1997$3.60M-140.4%
- 1996−$8.90M-18.3%
- 1995−$10.90M-9.9%
- 1994−$12.10M+146.9%
- 1993−$4.90M—
Operating Income values are taken from Incyte's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at Incyte (INCY)
According to Incyte's latest reported financial statements, the company's current operating income (TTM) is $1.45B. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Incyte (INCY) reported operating income of $1.34B – surged 1225.6% year-over-year.
Over 2015–2025 (10 years), Incyte operating income expanded at a +38.8% compound annual rate, with mixed annual results across the window.
2025 marks the peak operating income at $1.34B, with the historical low of −$263.68M recorded in 2020.
Incyte Operating Income by Year
Incyte Operating Income 2025: $1.34B
Incyte posted operating income of $1.34B in 2025, surged 1225.6% from 2024. This figure represents the highest annual value in the available history.
Incyte Operating Income 2024: $101.29M
In 2024, Incyte reported operating income of $101.29M, plunged 84.5% below 2023.
Incyte Operating Income 2023: $655.36M
Incyte operating income in 2023 was $655.36M, grew 10.8% from 2022.
Incyte Operating Income 2022: $591.63M
2022's operating income for Incyte came in at $591.63M, edged up 1.0% from 2021.
Incyte Operating Income 2021: $585.78M
Incyte operating income in 2021 was $585.78M.
See more financial history for Incyte (INCY).
Sector peers by Operating Income
Healthcare peers of Incyte (INCY), ranked by their latest operating income
| $29.70B | |
| $25.60B | |
| $23.49B | |
| $20.09B | |
| $19.90B | |
| $18.96B | |
| $13.74B | |
| $10.68B |
- $29.70B
- $25.60B
- $23.49B
- $20.09B
- $19.90B
- $18.96B
- $13.74B
- $10.68B
Frequently asked questions
Incyte (INCY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation